Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients

MLA

Federica Fogacci, et al. “Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients.” Journal of Clinical Medicine, vol. 11, Aug. 2022, p. 4701. EBSCOhost, https://doi.org/10.3390/jcm11164701.

APA

Federica Fogacci, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi, & Arrigo F. G. Cicero. (2022). Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients. Journal of Clinical Medicine, 11, 4701. https://doi.org/10.3390/jcm11164701

Chicago

Federica Fogacci, Marina Giovannini, Elisa Grandi, Egidio Imbalzano, Daniela Degli Esposti, Claudio Borghi, and Arrigo F. G. Cicero. 2022. “Management of High-Risk Hypercholesterolemic Patients and PCSK9 Inhibitors Reimbursement Policies: Data from a Cohort of Italian Hypercholesterolemic Outpatients.” Journal of Clinical Medicine 11 (August): 4701. doi:10.3390/jcm11164701.